Messenger RNA-based Vaccines: A Nobel Prize Worthy Invention
This morning, Pfizer and BioNTech announced some very positive results regarding the trial of their messenger RNA-based Coronavirus vaccine. The efficacy was found to be above 90%, which vastly exceeded expectations. The implications are profound, and include a proof point that genetic vaccines (a brand new highly extensible technology) can be very effective. In addition the medical community will now have a much higher confidence that the human immune system will respond to coronavirus vaccines with some form of lasting immunity. Further, the invention of messenger RNA vaccine technology (and genetic vaccine tech in general) will have highly impactful medical uses in the future. Some applications may include the treatment of diseases where the body can't make a proper version of a particular protein (such as sickle cell anemia among many others). This invention is perhaps one of the most impactful of the decade. The Dow is up over 1200 po...